Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 28;10(1):18.
doi: 10.3390/toxins10010018.

Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures

Affiliations
Review

Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures

Katharine E Alter et al. Toxins (Basel). .

Abstract

Injections of botulinum neurotoxins (BoNTs) are prescribed by clinicians for a variety of disorders that cause over-activity of muscles; glands; pain and other structures. Accurately targeting the structure for injection is one of the principle goals when performing BoNTs procedures. Traditionally; injections have been guided by anatomic landmarks; palpation; range of motion; electromyography or electrical stimulation. Ultrasound (US) based imaging based guidance overcomes some of the limitations of traditional techniques. US and/or US combined with traditional guidance techniques is utilized and or recommended by many expert clinicians; authors and in practice guidelines by professional academies. This article reviews the advantages and disadvantages of available guidance techniques including US as well as technical aspects of US guidance and a focused literature review related to US guidance for chemodenervation procedures including BoNTs injection.

Keywords: anatomic localization; botulinum neurotoxin; botulinum toxin; chemodenervation; electrical stimulation; electromyography; guidance; motor points; ultrasound.

PubMed Disclaimer

Conflict of interest statement

Alter has received royalties from Demos Medical Publishing.

Figures

Figure 1
Figure 1
(a) Transverse B-mode image, dDistal 1/3 Arm, anterior/flexor muscles; (b) longiudinal B-mode image, distal 1/3 Arm, anterior/flexor muscles.
Figure 2
Figure 2
(a) Transverse B-mode ultrasound (US) image, distal flexor foream/wrist; (b) longaxis B-mode US image, distal flexor foream/wrist.
Figure 3
Figure 3
B-mode ultrasound image, parotid salivary gland.
Figure 4
Figure 4
Ultrasound transducers.
Figure 5
Figure 5
(a) Transverse B-mode US image, Proximal Thigh; (b) transverse B-mode US image, Interscalene Triangle; (c) transverse B-mode US Image, hand (palmar view); (d) transverse B-mode US image, posterior calf (Distal 1/3).
Figure 5
Figure 5
(a) Transverse B-mode US image, Proximal Thigh; (b) transverse B-mode US image, Interscalene Triangle; (c) transverse B-mode US Image, hand (palmar view); (d) transverse B-mode US image, posterior calf (Distal 1/3).
Figure 6
Figure 6
(a) Long-axis B-mode US image, hand (palmar surface); (b) long-axis B-mode US image, anterior neck; (c) long-axis B-mode US image, flexor forearm.
Figure 6
Figure 6
(a) Long-axis B-mode US image, hand (palmar surface); (b) long-axis B-mode US image, anterior neck; (c) long-axis B-mode US image, flexor forearm.
Figure 7
Figure 7
(a) Longitudinal B-mode US image, inplane injection; (b) transverse B-mode US image, out of plane injection medial gastrocnemius; (c) illustration, out of plane view of needle tip and shaft.
Figure 7
Figure 7
(a) Longitudinal B-mode US image, inplane injection; (b) transverse B-mode US image, out of plane injection medial gastrocnemius; (c) illustration, out of plane view of needle tip and shaft.
Figure 8
Figure 8
(a) Flat angle of needle insertion using an in plane technique, effect on needle visualization. Needle is visualized; (b) steep angle of needle insertion using an in plane technique, effect on needle visualization. Visualization is lost due to anisotropy.

Comment in

Similar articles

Cited by

References

    1. Alter K.K., Nahab F.A. Comparison of Botulinum Neurotoxin Products. In: Alter K.K., Wilson N.A., editors. Botulinum Neurotoxin Injection Manual. Demos Medical Publishing; New York, NY, USA: 2015. pp. 10–18.
    1. Jankovic J. An update on new and unique uses of botulinum toxin in movement disorders. Toxicon. 2017 doi: 10.1016/j.toxicon.2017.09.003. - DOI - PubMed
    1. Lungu C., Ahmad O.F. Seminars in Neurology. Volume 36. Thieme Medical Publishers; Stuttgart, Germany: 2016. Update on the Use of Botulinum Toxin Therapy for Focal and Task-Specific Dystonias; pp. 41–46. - PubMed
    1. Simpson D.M., Hallett M., Ashman E.J., Comella C.L., Green M.V., Gronseth G.S., Armstrong M.J., Gloss D., Potrebic S., Jankovic J., et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86:1818–1826. doi: 10.1212/WNL.0000000000002560. - DOI - PMC - PubMed
    1. Orsini M., Leite M.M., Chung T.T., Bocca W., de Souza J.J., de Souza O.O., Moreira R.R., Bastos V.V., Teixeira S., Oliveira A.A., et al. Botulinum neurotoxin type A in neurology: Update. Neurol. Int. 2015;7:31–35. doi: 10.4081/ni.2015.5886. - DOI - PMC - PubMed

Publication types

LinkOut - more resources